Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001193805-23-000842

Options or other derivatives

  • Director acquired 11,297 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BVF PARTNERS L P/IL · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-08 Grant or award : show line 1 in the form Option to Buy +11,297 11,297 I
Loading xslF345X04/e618706_4-moonlake.xml…